Expertise in
11
conditions

Nicola Silvestris

Bari, IT 
Expertise in
11
conditions
Bari, IT 

Overview

Nicola Silvestris practices practicing medicine in Bari, Italy.

Ms. Silvestris is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Tissue Biopsy.

She is actively involved in clinical research, co-authoring 333 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Bari, 70124, Italy
Other Locations
Messina, Italy
Rome, Italy
Udine, 33100, Italy
Campobasso, 86100, Italy
70124, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
A Randomized Phase III Study Of Low-Docetaxel Oxaliplatin, Capecitabine (Low-Tox) Vs Epirubicin, Oxaliplatin And Capecitabine (Eox) In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer
Enrollment Status: Terminated
Publish Date: October 09, 2019
Intervention Type: Drug
Study Phase: Phase 3

333 Total Publications

RETRACTED: Safaee et al. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines. Molecules 2021, 26, 901.
RETRACTED: Safaee et al. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines. Molecules 2021, 26, 901.
Journal: Molecules (Basel, Switzerland)
Published: July 16, 2026

Frequently Asked Questions about Nicola Silvestris

Is Nicola Silvestris a top-rated expert for Cholangiocarcinoma (Bile Duct Cancer)?

MediFind is an objective health platform that identifies experts based on real-world data. Nicola Silvestris is classified as an Distinguished expert for Cholangiocarcinoma (Bile Duct Cancer), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nicola Silvestris participate in research or clinical trials?

Yes. Nicola Silvestris has published 333 articles and abstracts on conditions like Cholangiocarcinoma (Bile Duct Cancer). You can view a list of Nicola Silvestris's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Silvestris's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile